Hemoperfusion Adsorbent Resin Market Report – Research, Industry Analysis Reports and Market Demands

Global Hemoperfusion Adsorbent Resin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Target Toxin
- 1.3.1 Overview: Global Hemoperfusion Adsorbent Resin Consumption Value by Target Toxin: 2021 Versus 2025 Versus 2032
- 1.3.2 Medium Molecule Toxins
- 1.3.3 Protein Bound Toxins
- 1.3.4 Inflammatory Cytokines
- 1.3.5 Pathogenic Antibodies & Immune Complexes
- 1.3.6 Others
1.4 Market Analysis by Base Polymer Matrix
- 1.4.1 Overview: Global Hemoperfusion Adsorbent Resin Consumption Value by Base Polymer Matrix: 2021 Versus 2025 Versus 2032
- 1.4.2 Styrene-divinylbenzene
- 1.4.3 Polymethacrylate
- 1.4.4 Polyacrylate-based
- 1.4.5 Composite / Hybrid
- 1.4.6 Others
1.5 Market Analysis by Average Pore Size
- 1.5.1 Overview: Global Hemoperfusion Adsorbent Resin Consumption Value by Average Pore Size: 2021 Versus 2025 Versus 2032
- 1.5.2 Microporous Resin ＜2 nm
- 1.5.3 Mesoporous Resin 2–50 nm
- 1.5.4 Macroporous Resin ＞50 nm
- 1.5.5 Others
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Hemoperfusion Adsorbent Resin Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Uremic Toxin Removal
- 1.6.3 Acute Poisoning Rescue
- 1.6.4 Liver Failure Support
- 1.6.5 Sepsis and Cytokine Removal
- 1.6.6 Immunoadsorption Therapy
- 1.6.7 Others
1.7 Global Hemoperfusion Adsorbent Resin Market Size & Forecast
- 1.7.1 Global Hemoperfusion Adsorbent Resin Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Hemoperfusion Adsorbent Resin Sales Quantity (2021-2032)
- 1.7.3 Global Hemoperfusion Adsorbent Resin Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Hemoperfusion Adsorbent Resin by Manufacturer

3.1 Global Hemoperfusion Adsorbent Resin Sales Quantity by Manufacturer (2021-2026)
3.2 Global Hemoperfusion Adsorbent Resin Revenue by Manufacturer (2021-2026)
3.3 Global Hemoperfusion Adsorbent Resin Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Hemoperfusion Adsorbent Resin by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Hemoperfusion Adsorbent Resin Manufacturer Market Share in 2025
- 3.4.3 Top 6 Hemoperfusion Adsorbent Resin Manufacturer Market Share in 2025
3.5 Hemoperfusion Adsorbent Resin Market: Overall Company Footprint Analysis
- 3.5.1 Hemoperfusion Adsorbent Resin Market: Region Footprint
- 3.5.2 Hemoperfusion Adsorbent Resin Market: Company Product Type Footprint
- 3.5.3 Hemoperfusion Adsorbent Resin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Hemoperfusion Adsorbent Resin Market Size by Region
- 4.1.1 Global Hemoperfusion Adsorbent Resin Sales Quantity by Region (2021-2032)
- 4.1.2 Global Hemoperfusion Adsorbent Resin Consumption Value by Region (2021-2032)
- 4.1.3 Global Hemoperfusion Adsorbent Resin Average Price by Region (2021-2032)
4.2 North America Hemoperfusion Adsorbent Resin Consumption Value (2021-2032)
4.3 Europe Hemoperfusion Adsorbent Resin Consumption Value (2021-2032)
4.4 Asia-Pacific Hemoperfusion Adsorbent Resin Consumption Value (2021-2032)
4.5 South America Hemoperfusion Adsorbent Resin Consumption Value (2021-2032)
4.6 Middle East & Africa Hemoperfusion Adsorbent Resin Consumption Value (2021-2032)

5 Market Segment by Target Toxin

5.1 Global Hemoperfusion Adsorbent Resin Sales Quantity by Target Toxin (2021-2032)
5.2 Global Hemoperfusion Adsorbent Resin Consumption Value by Target Toxin (2021-2032)
5.3 Global Hemoperfusion Adsorbent Resin Average Price by Target Toxin (2021-2032)

6 Market Segment by Application

6.1 Global Hemoperfusion Adsorbent Resin Sales Quantity by Application (2021-2032)
6.2 Global Hemoperfusion Adsorbent Resin Consumption Value by Application (2021-2032)
6.3 Global Hemoperfusion Adsorbent Resin Average Price by Application (2021-2032)

7 North America

7.1 North America Hemoperfusion Adsorbent Resin Sales Quantity by Target Toxin (2021-2032)
7.2 North America Hemoperfusion Adsorbent Resin Sales Quantity by Application (2021-2032)
7.3 North America Hemoperfusion Adsorbent Resin Market Size by Country
- 7.3.1 North America Hemoperfusion Adsorbent Resin Sales Quantity by Country (2021-2032)
- 7.3.2 North America Hemoperfusion Adsorbent Resin Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Hemoperfusion Adsorbent Resin Sales Quantity by Target Toxin (2021-2032)
8.2 Europe Hemoperfusion Adsorbent Resin Sales Quantity by Application (2021-2032)
8.3 Europe Hemoperfusion Adsorbent Resin Market Size by Country
- 8.3.1 Europe Hemoperfusion Adsorbent Resin Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Hemoperfusion Adsorbent Resin Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Hemoperfusion Adsorbent Resin Sales Quantity by Target Toxin (2021-2032)
9.2 Asia-Pacific Hemoperfusion Adsorbent Resin Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Hemoperfusion Adsorbent Resin Market Size by Region
- 9.3.1 Asia-Pacific Hemoperfusion Adsorbent Resin Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Hemoperfusion Adsorbent Resin Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Hemoperfusion Adsorbent Resin Sales Quantity by Target Toxin (2021-2032)
10.2 South America Hemoperfusion Adsorbent Resin Sales Quantity by Application (2021-2032)
10.3 South America Hemoperfusion Adsorbent Resin Market Size by Country
- 10.3.1 South America Hemoperfusion Adsorbent Resin Sales Quantity by Country (2021-2032)
- 10.3.2 South America Hemoperfusion Adsorbent Resin Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Hemoperfusion Adsorbent Resin Sales Quantity by Target Toxin (2021-2032)
11.2 Middle East & Africa Hemoperfusion Adsorbent Resin Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Hemoperfusion Adsorbent Resin Market Size by Country
- 11.3.1 Middle East & Africa Hemoperfusion Adsorbent Resin Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Hemoperfusion Adsorbent Resin Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Hemoperfusion Adsorbent Resin Market Drivers
12.2 Hemoperfusion Adsorbent Resin Market Restraints
12.3 Hemoperfusion Adsorbent Resin Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Hemoperfusion Adsorbent Resin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hemoperfusion Adsorbent Resin
13.3 Hemoperfusion Adsorbent Resin Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Hemoperfusion Adsorbent Resin Typical Distributors
14.3 Hemoperfusion Adsorbent Resin Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Hemoperfusion Adsorbent Resin market size was valued at US$ 221 million in 2025 and is forecast to a readjusted size of US$ 431 million by 2032 with a CAGR of 10.0% during review period.
Hemoperfusion adsorbent resin refers to macroporous adsorption resin materials based on a styrene divinylbenzene copolymer backbone, prepared through pore forming, crosslinking, and surface modification processes, specifically designed for selective adsorption and removal of pathogenic substances from blood during hemoperfusion therapy. The core characteristic lies in the three dimensional porous network structure and high specific surface area that capture target toxins through physicochemical adsorption mechanisms, while biocompatible surface modification enables direct blood contact without significant adverse reactions. Major product configurations include broad spectrum adsorbent resins for removing medium to large molecular weight uremic toxins, functionalized resins for specific cytokine removal, ion exchange resins for bilirubin adsorption, and antigen antibody immobilized resins for immunoadsorption. The technological process encompasses suspension polymerization to prepare the resin backbone, chloromethylation and post crosslinking to construct the pore structure, and surface chemical modification to impart specific adsorption functionality. Key technical specifications include particle size distribution, specific surface area, average pore diameter, pore volume, moisture content, and dynamic adsorption rate. The critical functions of this material include efficient removal of beta 2 microglobulin and parathyroid hormone in end stage renal disease patients, organophosphorus and barbiturate compounds in poisoned patients, bilirubin and endotoxins in severe hepatitis patients, inflammatory cytokines in sepsis patients, and pathogenic antibodies in autoimmune disease patients. Primary applications cover hemoperfusion for chronic kidney disease, acute poisoning emergency treatment, artificial liver support therapy, sepsis blood purification, and immunoadsorption therapy. The average gross margin in the global hemoperfusion adsorbent resin industry for 2025 is estimated between 40 and 60 percent. The average unit price for medical grade macroporous adsorbent resin ranges from 500 to 15,000 US dollars per kilogram, with premium pricing for high end functionalized immunoadsorption media and high specific surface area specialty resins. Actual prices and consumption vary significantly depending on adsorption specificity type, specific surface area grade, biocompatible modification level, and medical device certification status.
The hemoperfusion adsorbent resin industry occupies the mid to upstream position in the medical device supply chain. Upstream suppliers provide petrochemical raw materials, midstream manufacturers focus on resin synthesis and surface modification capabilities, and downstream customers include hemoperfusion cartridge manufacturers and end user medical institutions. Resin material costs account for approximately one fifth to one quarter of the total hemoperfusion cartridge cost structure, with technical barriers concentrated in pore size distribution control, surface biocompatibility modification, and specific ligand immobilization. Chinese companies have taken a leading position in full industry chain integration and clinical application promotion, while international companies maintain deep expertise in basic resin synthesis platforms and functional modification technologies. Regional supply chains show clear concentration characteristics, with China serving as both the largest hemoperfusion treatment market globally and the core production base for adsorbent resins.
Demand growth for hemoperfusion adsorbent resins globally is driven by multiple factors. Rising incidence rates of chronic kidney disease continue expanding the base of end stage renal disease patients, while penetration rates of hemoperfusion combined with hemodialysis treatment continue increasing under the impetus of medical insurance coverage expansion, which directly drives upstream adsorbent resin demand. Expansion of therapeutic indications into areas including acute poisoning, severe hepatitis, sepsis, and autoimmune diseases has opened new application spaces for adsorbent resins, driving product iteration toward functionalized and highly selective adsorbent resins. From a policy perspective, multiple regions have incorporated hemoperfusion therapy into medical insurance reimbursement coverage, significantly improving patient accessibility. Industry dynamics show leading manufacturers continuously increasing research and development investment, launching highly selective adsorbent resin products targeting specific toxin molecules, while simultaneously expanding medical adsorbent resin production bases to ensure supply chain security, with some manufacturers beginning to explore overseas markets.
In the coming years, the hemoperfusion adsorbent resin industry will maintain relatively rapid growth, though internal industry structure is undergoing transformation. As hemoperfusion therapy indications continue expanding and global exploration of non dialysis treatment pathways advances, total demand for adsorbent resins will continue expanding. Simultaneously, the trend of downstream cartridge manufacturers integrating upward into resin production is reshaping the supply structure, with traditional independent resin suppliers facing pressure from increasing self production ratios among customers, driving some companies to seek new growth space through technological innovation and differentiated products. From a competitive landscape perspective, companies possessing full industry chain integration capabilities, mastery of core surface modification technologies, and stable clinical validation data will achieve sustainable competitive advantages. Alternative technologies including specific antibody adsorption and nanomaterial adsorption routes are forming competition in certain segments, but macroporous adsorbent resins will maintain their mainstream material position in hemoperfusion therapy due to their broad spectrum adsorption capacity, cost advantages, and long term clinical validation.
This report is a detailed and comprehensive analysis for global Hemoperfusion Adsorbent Resin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Target Toxin and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hemoperfusion Adsorbent Resin market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (kUSD/kg), 2021-2032
Global Hemoperfusion Adsorbent Resin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (kUSD/kg), 2021-2032
Global Hemoperfusion Adsorbent Resin market size and forecasts, by Target Toxin and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (kUSD/kg), 2021-2032
Global Hemoperfusion Adsorbent Resin market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (kUSD/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemoperfusion Adsorbent Resin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hemoperfusion Adsorbent Resin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jafron Biomedical Co., Ltd., Hebei Lijiang Biotechnology Co., Ltd., Zibo Purui Resin Technology Co., Ltd., Weihai Weigao Yangquan Bio Co., Ltd., Tianjin Yangquan Medical Instrument Co., Ltd., Chongqing Xierkang Blood Purification Equipment R&D Co., Ltd., Mitsubishi Chemical Corporation, Purolite, LANXESS, Asahi Kasei Medical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hemoperfusion Adsorbent Resin market is split by Target Toxin and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Target Toxin, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Target Toxin
Medium Molecule Toxins
Protein Bound Toxins
Inflammatory Cytokines
Pathogenic Antibodies & Immune Complexes
Others
Market segment by Base Polymer Matrix
Styrene-divinylbenzene
Polymethacrylate
Polyacrylate-based
Composite / Hybrid
Others
Market segment by Average Pore Size
Microporous Resin ＜2 nm
Mesoporous Resin 2–50 nm
Macroporous Resin ＞50 nm
Others
Market segment by Application
Uremic Toxin Removal
Acute Poisoning Rescue
Liver Failure Support
Sepsis and Cytokine Removal
Immunoadsorption Therapy
Others
Major players covered
Jafron Biomedical Co., Ltd.
Hebei Lijiang Biotechnology Co., Ltd.
Zibo Purui Resin Technology Co., Ltd.
Weihai Weigao Yangquan Bio Co., Ltd.
Tianjin Yangquan Medical Instrument Co., Ltd.
Chongqing Xierkang Blood Purification Equipment R&D Co., Ltd.
Mitsubishi Chemical Corporation
Purolite
LANXESS
Asahi Kasei Medical Co., Ltd.
Kaneka Corporation
CytoSorbents Corporation
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemoperfusion Adsorbent Resin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemoperfusion Adsorbent Resin, with price, sales quantity, revenue, and global market share of Hemoperfusion Adsorbent Resin from 2021 to 2026.
Chapter 3, the Hemoperfusion Adsorbent Resin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemoperfusion Adsorbent Resin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Target Toxin and by Application, with sales market share and growth rate by Target Toxin, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hemoperfusion Adsorbent Resin market forecast, by regions, by Target Toxin, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemoperfusion Adsorbent Resin.
Chapter 14 and 15, to describe Hemoperfusion Adsorbent Resin sales channel, distributors, customers, research findings and conclusion.

Buy now